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inflammation. Recent research has shown that SFN
and TNF-α may have synergistic effects when used
together. Previous research has shown that TNF-α
may activate NF-κB, an anti-apoptotic transcription
factor (Figure 1).

Abstract
The primary goal of modern cancer therapeutic
regiments is to develop treatments that are
damaging to tumor cells but maintain the health of
normal somatic cells. The “cocktails” of drugs used
in current cancer treatment can interact in a
mechanism that is not adequately understood.
However, it is sometimes possible to use
combinations of different chemicals to achieve the
desired effect of killing the most cancer cells
possible while preserving the patient’s other rapidly
dividing cells. Our work to this point has been
focused on two chemicals, sulforaphane (SFN), a
organosulfur compound found in cruciferous
vegetables, and Tumor Necrosis Factor-α (TNF), a
cytokine involved in regulation of the immune
response. The scope of our research is centered
around apoptosis, or programmed cell death. In this
project, we tested the effects of combining SFN
treatment with varying amounts of TNF-α based on
prior research from the O’Donnell lab showing the
combination of SFN and TNF-α together cause
apoptosis despite the fact that TNF-α alone is an
insufficient inducing agent. In our preliminary
experiments using cytotoxicity assays, we did find
increased killing when the drugs were used in
combination. Experiments using caspase 3
apoptosis assays showed an increase in apoptosis
with the combined treatment due to activation of
the caspase 3 pathway. Moving forward, we have
begun to investigate how altering gene regulation
proteins might sensitize the cells to apoptosis
induction via the use of 5-Azacytidine, a DNA
methyltransferase inhibitor.

Figure 1. Membrane domain of TNF pathway and
chemical structure of sulforaphane

Apoptosis is the process of programmed cell death
and cancer cells often have mutations that prevent
them from undergoing entering this process. TNF-α
activates procaspase 8 which activates the
executioner caspases, including caspase 3.
Sulforaphane has also been shown to induce
apoptosis through activation of reactive oxygen
species-dependent caspase-3. This combination of
drugs actually has a more lethal effect than either
drug alone, leading to more apoptotic cells.
Developing hypothesis look to test the levels of cell
proliferation after first sensitizing the cells with 5Azacytidine, a methyltransferase inhibitor (Figure
2.)

Introduction
The cell line we work with is HTB-26, derived
from a 51 year old Caucasian female patient with
breast cancer in 1979 (Cailleau). It can be described
as an adenocarcinoma of the mammary gland that is
derived from epithelial tissue. This cell line is
tumorigenic in immunocompromised mice. One of
the drugs we worked with is SFN, an
isothiocyanate derived from broccoli and other
cruciferous vegetables (Figure 1) (Jakubikova).
Tumor necrosis factor α is a cytokine involved in
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various amounts of TNF, or nothing. The cells were
incubated for 72 hours. MTT was prepared and
20µL was added to each well and incubated for 5
hours. The supernatant was removed and 100µL of
a mixture composed of 9.6 mL isopropanol and 0.4
mL HCl (1N) was added before the plate was read
for fluorescence at 585 and 690 nm.
Figure 2. Chemical structure of 5-Azacytidine.
Results
Materials
Cytotoxicity experiments for HTB 26 cell lines
revealed that the concentration of drug that showed
the desired amount of killing was 0.035 mM, which
ultimately came out to be 0.5mL of 0.28mM of
SFN for every 4mLs of cells. The MTT cell
proliferation assay detected an additional 7%
killing in the presence of TNF, on top of the 57%
caused by SFN alone. As the concentration of TNF
increased, the amount of killing followed
proportionally (figure 3). Results from the
apoptosis assay, as depicted in figure 4, suggest that
TNF and SFN may have a synergistic effect in
inducing apoptosis, since the combination induced
higher levels than the additive effects of the drugs
alone. The CyQuant Assay illustrates that TNF
alone is a poor killing agent, obtaining only a 6%
increase from the cell control. However, TNF
supplements the strong killing induced by SFN by
an additional 6-7% (Figure 5).

Dulbecco’s PBS (Phosphate Buffered Saline),
Trypsin, RPMI (Rochester Park Memorial
Institute), L-15 Medium (Leibovitz), L-15, FBS
(Fetal Bovine Serum), Glutamax, TNF-α, SFN,
Annexin V Kit (10x Binding Buffer, PI, Annexin,
Distilled H20) , Caspase-3 Assay (Lysis Buffer, 2x
Reaction Buffer 3, DTT, Caspase-3 calorimetric
substrate), CyQuant Assay (CyQuant GR dye, Celllysis buffer, DNA standard). MTT, isopropanol, 1N
HCl.
Methods
Cyquant Assay : A 96 well plate was set up after
cells were cultured and incubated. Each well
received 100µL of media. SFN was kept constant in
all wells through column 10. The bottom four rows
received varying amounts of TNF. The plate was
incubated at 370 C for 72 hrs and excess fluids were
removed by flicking and blotting. A CyQuant assay
was prepared, and added to each well and the
fluorescence was measured. These experiments
allowed us to verify the dosages to use in future
experiments.
Caspase 3 Assay: Cells were treated with nothing,
SFN, tumor necrosis factor-α or a combination of
drugs for 72 hours. Cells are collected by
centrifugation at 250G for 10 minutes. The cells
were lysed and then centrifuged. In a 96 well plate,
50 µL of each sample was added to each well along
with 50 µL of 2x Reaction Buffer 3 and 5 µL of
Caspase-3 colorimetric substrate . The plate was
incubated for 1-2 hours at 370 C and absorbance
was read at 405 nm.

Figure 3. Graph depicting cell survival of HTB-26
cells when incubated in uniform amounts of
sulforaphane, while varying the amounts of TNF in
the experimental rows. Different doses of TNF are
distinguished by separate lines

MTT Assay: a 96 well plate was set up to measure
cell proliferation. Cells from the breast cancer line
HTB-26 were exposed to SFN alone, SFN and
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Discussion
Overall data provides support for the notion that
SFN causes cytotoxicity in HTB-26 cells and that a
combination of TNF-α and SFN has a greater
apoptosis inducing effect. This can have great
clinical implications if it is able to kill cancer cells
more effectively in vitro. However, treatment
would have to be relatively safe to the body’s noncancerous cells, which divide at various rates. The
new direction we are following is to determine
whether 5-Azacytidine treatment will first weaken
cells so they will be more sensitive to apoptosis
induction with Sulforaphane and Tumor Necrosis
Factor-α . Our further studies will examine the
influence these experiments will have on MRC-5
human fibroblasts (non-cancerous cells) and how 5Azacytidine might enhance previously obtained
results.

Figure 4. Apoptosis Enrichment of HTB-26 cells
based on all experimental treatments of SFN, TNF
and a combination of both vs. a cell control that
received no drug.
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Figure 5. Results from CyQuant Assay for cell
survival of each experimental group.
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